Dansk Erhvervsinvestering

A/S Dansk Erhvervsinvestering is a Danish venture capital and private equity firm founded in 1983 and headquartered in Copenhagen. The firm has historically been a prominent investor in the Danish life sciences and biotechnology sectors, providing critical early-stage and expansion capital to companies that have become industry leaders, such as Genmab and Zealand Pharma. Currently operating as a subsidiary of the AKF Group, the company manages a diverse portfolio of equity investments and is also involved in commercial real estate holdings. Its investment strategy has traditionally focused on Danish businesses with high growth potential and international scalability. The firm is recognized for its long-standing contribution to the Danish innovation ecosystem, particularly in healthcare and medical technology.